Study Details

Weight Gain Associated with the Use of Anti-Hyperglycemic Therapies for Type 2 Diabetes

Gregory A. Nichols, Principal Investigator


The goals of this study are to determine the independent association between weight gain and use of various anti-hyperglycemic therapies and to identify other factors associated with weight gain, including glycemic control, blood pressure, duration of diabetes, age, gender, and the presence of comorbidities.
Funding source: Bristol-Myers-Squibb Company

Our Locations
Three Regions — One Mission
Each CHR site conducts professionally independent, public domain research and disseminates its findings in the scholarly literature and scientific community.

Northwest
 3800 N. Interstate
Portland, OR 97227      
503.335.2400

Hawaii
 711 Kapiolani Blvd.
Suite 200
Honolulu, HI 96813
101.222.2400 		Southeast
 3495 Piedmont Road, NE
Ten Piedmont Center,
Suite 205
Atlanta, GA 30305
202.555.1212

US Map

 
Kaiser Permanente